{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,9]],"date-time":"2026-04-09T20:31:58Z","timestamp":1775766718621,"version":"3.50.1"},"reference-count":60,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Immunology and Allergy Clinics of North America"],"published-print":{"date-parts":[[2023,11]]},"DOI":"10.1016\/j.iac.2023.04.002","type":"journal-article","created":{"date-parts":[[2023,5,22]],"date-time":"2023-05-22T15:50:09Z","timestamp":1684770609000},"page":"699-710","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["Drug and Venom Allergy in Mastocytosis"],"prefix":"10.1016","volume":"43","author":[{"given":"Matthew P.","family":"Giannetti","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jennifer","family":"Nicoloro-SantaBarbara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Grace","family":"Godwin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julia","family":"Middlesworth","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew","family":"Espeland","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mariana C.","family":"Castells","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.iac.2023.04.002_bib1","doi-asserted-by":"crossref","DOI":"10.1016\/j.iac.2018.04.010","article-title":"Hymenoptera Anaphylaxis as a Clonal Mast Cell Disorder","volume":"38","author":"Bonadonna","year":"2018","journal-title":"Immunol Allergy Clin North Am"},{"issue":"2","key":"10.1016\/j.iac.2023.04.002_bib2","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaci.2013.06.020","article-title":"Nonaggressive systemic mastocytosis (SM) without skin lesions associated with insect-induced anaphylaxis shows unique features versus other indolent SM","volume":"133","author":"\u00c1lvarez-Twose","year":"2014","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"4","key":"10.1016\/j.iac.2023.04.002_bib3","doi-asserted-by":"crossref","DOI":"10.1097\/ACI.0b013e32833b280c","article-title":"Mastocytosis and insect venom allergy","volume":"10","author":"Bonadonna","year":"2010","journal-title":"Curr Opin Allergy Clin Immunol"},{"issue":"1","key":"10.1016\/j.iac.2023.04.002_bib4","doi-asserted-by":"crossref","DOI":"10.1001\/archinte.161.1.15","article-title":"Anaphylaxis in the United States","volume":"161","author":"Neugut","year":"2001","journal-title":"Arch Intern Med"},{"issue":"11","key":"10.1016\/j.iac.2023.04.002_bib5","doi-asserted-by":"crossref","DOI":"10.1111\/all.12272","article-title":"The epidemiology of anaphylaxis in Europe: A systematic review","volume":"68","author":"Panesar","year":"2013","journal-title":"Allergy: European Journal of Allergy and Clinical Immunology"},{"issue":"3","key":"10.1016\/j.iac.2023.04.002_bib6","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaci.2008.11.018","article-title":"Clonal mast cell disorders in patients with systemic reactions to Hymenoptera stings and increased serum tryptase levels","volume":"123","author":"Bonadonna","year":"2009","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"2","key":"10.1016\/j.iac.2023.04.002_bib7","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1111\/j.1398-9995.2007.01569.x","article-title":"Anaphylaxis in patients with mastocytosis: a study on history, clinical features and risk factors in 120 patients","volume":"63","author":"Brockow","year":"2008","journal-title":"Allergy"},{"issue":"10","key":"10.1016\/j.iac.2023.04.002_bib8","doi-asserted-by":"crossref","DOI":"10.1111\/j.1365-2222.2007.02804.x","article-title":"Prevalence of allergy and anaphylactic symptoms in 210 adult and pediatric patients with mastocytosis in Spain: A study of the Spanish network on mastocytosis (REMA)","volume":"37","author":"Gonz\u00e1lez De Olano","year":"2007","journal-title":"Clin Exp Allergy"},{"issue":"1","key":"10.1016\/j.iac.2023.04.002_bib9","doi-asserted-by":"crossref","DOI":"10.1111\/cea.12225","article-title":"High prevalence of anaphylaxis in patients with systemic mastocytosis - a single-centre experience","volume":"44","author":"G\u00fclen","year":"2014","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.iac.2023.04.002_bib10","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/S0091-6749(97)81058-5","article-title":"Fatal anaphylaxis after a yellow jacket sting, despite venom immunotherapy, in two patients with mastocytosis","volume":"99","author":"Oude Elberink","year":"1997","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"5","key":"10.1016\/j.iac.2023.04.002_bib11","article-title":"Risk Factor Analysis of Anaphylactic Reactions in Patients With Systemic Mastocytosis","volume":"5","author":"G\u00fclen","year":"2017","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"issue":"5","key":"10.1016\/j.iac.2023.04.002_bib12","article-title":"Mastocytosis and allergic diseases","volume":"24","author":"Bonadonna","year":"2014","journal-title":"J\u00a0Investig Allergol Clin Immunol"},{"issue":"1","key":"10.1016\/j.iac.2023.04.002_bib13","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaci.2012.12.1578","article-title":"Higher mast cell load decreases the risk of Hymenoptera venom-induced anaphylaxis in patients with mastocytosis","volume":"132","author":"van Anrooij","year":"2013","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"1","key":"10.1016\/j.iac.2023.04.002_bib14","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaci.2014.11.035","article-title":"Clonal mast cell disorders in patients with severe Hymenoptera venom allergy and normal serum tryptase levels","volume":"136","author":"Zanotti","year":"2015","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"3","key":"10.1016\/j.iac.2023.04.002_bib15","doi-asserted-by":"crossref","DOI":"10.1111\/all.13945","article-title":"Risk factors and indicators of severe systemic insect sting reactions","volume":"75","author":"Stoevesandt","year":"2020","journal-title":"Allergy"},{"issue":"12","key":"10.1016\/j.iac.2023.04.002_bib16","doi-asserted-by":"crossref","DOI":"10.1111\/j.1398-9995.2005.00960.x","article-title":"Prevention and treatment of hymenoptera venom allergy: Guidelines for clinical practice","volume":"60","author":"Bonifazi","year":"2005","journal-title":"Allergy"},{"issue":"1","key":"10.1016\/j.iac.2023.04.002_bib17","doi-asserted-by":"crossref","DOI":"10.1016\/j.iac.2015.08.012","article-title":"Allergy Work-Up Including Component-Resolved Diagnosis: How to Make Allergen-Specific Immunotherapy More Specific","volume":"36","author":"Kleine-Tebbe","year":"2016","journal-title":"Immunol Allergy Clin North Am"},{"issue":"4","key":"10.1016\/j.iac.2023.04.002_bib18","article-title":"Usefulness of omalizumab and sting challenge test in hymenoptera venom allergy and mastocytosis","volume":"29","author":"Gonz\u00e1lez-de-Olano","year":"2019","journal-title":"J\u00a0Investig Allergol Clin Immunol"},{"issue":"5","key":"10.1016\/j.iac.2023.04.002_bib19","doi-asserted-by":"crossref","DOI":"10.2217\/imt.11.44","article-title":"Venom immunotherapy in patients with mastocytosis and hymenoptera venom anaphylaxis","volume":"3","author":"Gonz\u00e1lez-De-Olano","year":"2011","journal-title":"Immunotherapy"},{"issue":"4","key":"10.1016\/j.iac.2023.04.002_bib20","article-title":"How to diagnose mast cell activation syndrome: Practical considerations","volume":"130","author":"Romantowski","year":"2020","journal-title":"Pol Arch Intern Med"},{"issue":"1","key":"10.1016\/j.iac.2023.04.002_bib21","doi-asserted-by":"crossref","DOI":"10.1111\/all.13980","article-title":"Venom immunotherapy in patients with clonal mast cell disorders: IgG4 correlates with protection","volume":"75","author":"Jarkvist","year":"2020","journal-title":"Allergy"},{"issue":"4","key":"10.1016\/j.iac.2023.04.002_bib22","article-title":"One-day ultrarush desensitization for Hymenoptera venom anaphylaxis in patients with and without mast cell disorders with adjuvant omalizumab","volume":"8","author":"Giannetti","year":"2020","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"issue":"3","key":"10.1016\/j.iac.2023.04.002_bib23","doi-asserted-by":"crossref","DOI":"10.1002\/clt2.12132","article-title":"Mastocytosis presenting with mast cell-mediator release-associated symptoms elicited by cyclo oxygenase inhibitors: prevalence, clinical, and laboratory features","volume":"12","author":"Rama","year":"2022","journal-title":"Clin Transl Allergy"},{"issue":"3\u20134","key":"10.1016\/j.iac.2023.04.002_bib24","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.prostaglandins.2009.01.001","article-title":"Survey of aspirin administration in systemic mastocytosis","volume":"88","author":"Butterfield","year":"2009","journal-title":"Prostaglandins Other Lipid Mediat"},{"issue":"4","key":"10.1016\/j.iac.2023.04.002_bib25","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/j.jaip.2014.03.014","article-title":"Nonsteroidal anti-inflammatory drugs are major causes of drug-induced anaphylaxis","volume":"2","author":"Aun","year":"2014","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"issue":"7","key":"10.1016\/j.iac.2023.04.002_bib26","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1111\/all.12617","article-title":"Drug hypersensitivity in clonal mast cell disorders: ENDA\/EAACI position paper","volume":"70","author":"Bonadonna","year":"2015","journal-title":"Allergy"},{"key":"10.1016\/j.iac.2023.04.002_bib27","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.1056\/NEJM198706253162603","article-title":"Tryptase levels as an indicator of mast-cell activation in systemic anaphylaxis and mastocytosis","volume":"316","author":"Schwartz","year":"1987","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.iac.2023.04.002_bib28","doi-asserted-by":"crossref","first-page":"481","DOI":"10.4065\/70.5.481","article-title":"Aspirin Idiosyncrasy in systemic mast cell disease: a new look at mediator release during aspirin desensitization","volume":"70","author":"Butterfield","year":"1995","journal-title":"Mayo Clin Proc"},{"issue":"3","key":"10.1016\/j.iac.2023.04.002_bib29","first-page":"230","article-title":"Acetylsalicyls\u00e4ure-abh\u00e4ngige anaphylaxie auf karotte bei mastozytose","volume":"9","author":"Pfeffer","year":"2011","journal-title":"JDDG"},{"issue":"3","key":"10.1016\/j.iac.2023.04.002_bib30","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1016\/j.jaci.2018.10.063","article-title":"Adverse reactions to drugs and biologics in patients with clonal mast cell disorders: A Work Group Report of the Mast Cells Disorder Committee, American Academy of Allergy, Asthma & Immunology","volume":"143","author":"Carter","year":"2019","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"4","key":"10.1016\/j.iac.2023.04.002_bib31","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1159\/000144042","article-title":"Prevention of mast cell activation disorder-associated clinical sequelae of excessive prostaglandin D2 production","volume":"147","author":"Butterfield","year":"2008","journal-title":"Int Arch Allergy Immunol"},{"key":"10.1016\/j.iac.2023.04.002_bib32","first-page":"36","article-title":"Mastocytosis without urticaria pigmentosa: a frequently unrecognized cause of recurrent syncope","volume":"95","author":"Roberts","year":"1982","journal-title":"Trans Assoc Am Physicians"},{"key":"10.1016\/j.iac.2023.04.002_bib33","doi-asserted-by":"crossref","unstructured":"Cochran ST, Bomyea K, Sayre JW. Trends in adverse events after IV Administration of contrast media A.; 2001. www.ajronline.org.","DOI":"10.2214\/ajr.176.6.1761385"},{"issue":"6","key":"10.1016\/j.iac.2023.04.002_bib34","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaci.2010.02.019","article-title":"Clinical, biological, and molecular characteristics of clonal mast cell disorders presenting with systemic mast cell activation symptoms","volume":"125","author":"\u00c1lvarez-Twose","year":"2010","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"2","key":"10.1016\/j.iac.2023.04.002_bib35","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.iac.2014.01.014","article-title":"Drug allergy in mastocytosis","volume":"34","author":"Bonadonna","year":"2014","journal-title":"Immunol Allergy Clin North Am"},{"issue":"2","key":"10.1016\/j.iac.2023.04.002_bib36","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1111\/j.1398-9995.2008.01832.x","article-title":"Skin testing in patients with hypersensitivity reactions to iodinated contrast media - A European multicenter study","volume":"64","author":"Brockow","year":"2009","journal-title":"Allergy"},{"key":"10.1016\/j.iac.2023.04.002_bib37","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1177\/0310057X0903700415","article-title":"Anaphylactoid reaction to intravenous contrast in patient with systemic mastocytosis","volume":"37","author":"Weingarten","year":"2009","journal-title":"Anaesth Intensive Care"},{"issue":"1","key":"10.1016\/j.iac.2023.04.002_bib38","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.jaci.2018.02.018","article-title":"Hypersensitivity reactions to therapeutic monoclonal antibodies: Phenotypes and endotypes","volume":"142","author":"Isabwe","year":"2018","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"6","key":"10.1016\/j.iac.2023.04.002_bib39","doi-asserted-by":"crossref","first-page":"2505","DOI":"10.1016\/j.jaip.2020.11.066","article-title":"Successful administration of omalizumab by desensitization protocol following systemic reactions in 12 patients","volume":"9","author":"Bernaola","year":"2021","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"issue":"2","key":"10.1016\/j.iac.2023.04.002_bib40","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1213\/01.ANE.0000097168.32472.0D","article-title":"Opioid-Induced Mast Cell Activation and Vascular Responses Is Not Mediated by \u03bc-Opioid Receptors: An In\u00a0Vivo Microdialysis Study in Human Skin","volume":"98","author":"Blunk","year":"2004","journal-title":"Anesth Analg"},{"key":"10.1016\/j.iac.2023.04.002_bib41","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1097\/00000542-198405000-00020","article-title":"Hemodynamics and histamine release during induction with sufentanil or fentanyl","volume":"60","author":"Rosow","year":"1984","journal-title":"Anesthesiology"},{"issue":"2","key":"10.1016\/j.iac.2023.04.002_bib42","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/j.jaci.2011.03.003","article-title":"Anaphylaxis during anesthesia in France: An 8-year national survey","volume":"128","author":"Mertes","year":"2011","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"1","key":"10.1016\/j.iac.2023.04.002_bib43","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1159\/000436969","article-title":"Management of Anesthesia in Adult and Pediatric Mastocytosis: A Study of the Spanish Network on Mastocytosis (REMA) Based on 726 Anesthetic Procedures","volume":"167","author":"Matito","year":"2015","journal-title":"Int Arch Allergy Immunol"},{"issue":"4","key":"10.1016\/j.iac.2023.04.002_bib44","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.anai.2017.07.022","article-title":"Management around invasive procedures in mastocytosis: An update","volume":"119","author":"Hermans","year":"2017","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.iac.2023.04.002_bib45","doi-asserted-by":"crossref","unstructured":"Stellato C, Casolaro V, Ciccarelli A, et\u00a0al. General ANAESTHETICS INDUCE ONLY HISTAMINE RELEASE SELECTIVELY FROM HUMAN MAST CELLS. Vol 67.; 1991.","DOI":"10.1093\/bja\/67.6.751"},{"key":"10.1016\/j.iac.2023.04.002_bib46","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1097\/00000542-199106000-00016","article-title":"Heterogeneity of human mast cells and basophils in response to muscle relaxants","volume":"74","author":"Stellato","year":"1991","journal-title":"Anesthesiology"},{"issue":"2","key":"10.1016\/j.iac.2023.04.002_bib47","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.jaci.2021.03.049","article-title":"Multifaceted MRGPRX2: New insight into the role of mast cells in health and disease","volume":"148","author":"Roy","year":"2021","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"11","key":"10.1016\/j.iac.2023.04.002_bib48","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1002\/ajh.24490","article-title":"Risk of solid cancer, cardiovascular disease, anaphylaxis, osteoporosis and fractures in patients with systemic mastocytosis: A nationwide population-based study","volume":"91","author":"Broesby-Olsen","year":"2016","journal-title":"Am J Hematol"},{"issue":"24","key":"10.1016\/j.iac.2023.04.002_bib49","doi-asserted-by":"crossref","first-page":"2338","DOI":"10.1056\/NEJMra1807761","article-title":"Penicillin Allergy","volume":"381","author":"Castells","year":"2019","journal-title":"N\u00a0Engl J Med"},{"issue":"2","key":"10.1016\/j.iac.2023.04.002_bib50","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1034\/j.1398-9995.2003.00056_2.x","article-title":"Anaphylaxis during negative penicillin skin prick testing confirmed by elevated serum tryptase","volume":"58","author":"Alonso D\u00edaz De Durana","year":"2003","journal-title":"Allergy: European Journal of Allergy and Clinical Immunology"},{"issue":"2","key":"10.1016\/j.iac.2023.04.002_bib51","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1111\/bjd.14004","article-title":"Clinical features and course of cutaneous mastocytosis in 133 children","volume":"174","author":"Schena","year":"2016","journal-title":"Br J Dermatol"},{"issue":"10","key":"10.1016\/j.iac.2023.04.002_bib52","doi-asserted-by":"crossref","first-page":"3841","DOI":"10.1016\/j.jaip.2021.05.042","article-title":"Expression of MRGPRX2 in skin mast cells of patients with maculopapular cutaneous mastocytosis","volume":"9","author":"Deepak","year":"2021","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"issue":"7542","key":"10.1016\/j.iac.2023.04.002_bib53","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1038\/nature14022","article-title":"Identification of a mast-cell-specific receptor crucial for pseudo-allergic drug reactions","volume":"519","author":"McNeil","year":"2015","journal-title":"Nature"},{"issue":"6","key":"10.1016\/j.iac.2023.04.002_bib54","doi-asserted-by":"crossref","first-page":"2089","DOI":"10.1016\/j.jaip.2019.01.059","article-title":"Anaphylaxis to quinolones in mastocytosis: Hypothesis on the mechanism","volume":"7","author":"Giavina-Bianchi","year":"2019","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"issue":"3","key":"10.1016\/j.iac.2023.04.002_bib55","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1097\/00000542-199809000-00010","article-title":"Tryptase Levels Are Not Increased during Vancomycin-induced Anaphylactoid Reactions","volume":"89","author":"Renz","year":"1998","journal-title":"Anesthesiology"},{"issue":"6","key":"10.1016\/j.iac.2023.04.002_bib56","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1111\/j.1398-9995.2012.02812.x","article-title":"Increased serum baseline tryptase levels and extensive skin involvement are predictors for the severity of mast cell activation episodes in children with mastocytosis","volume":"67","author":"Alvarez-Twose","year":"2012","journal-title":"Allergy"},{"issue":"1","key":"10.1016\/j.iac.2023.04.002_bib57","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.jaip.2012.08.008","article-title":"Generalized Bullous Eruption after Routine Vaccination in a Child with Diffuse Cutaneous Mastocytosis","volume":"1","author":"Bankova","year":"2013","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"issue":"6","key":"10.1016\/j.iac.2023.04.002_bib58","doi-asserted-by":"crossref","first-page":"2139","DOI":"10.1016\/j.jaip.2021.03.041","article-title":"COVID-19 Vaccination in Mastocytosis: Recommendations of the European Competence Network on Mastocytosis (ECNM) and American Initiative in Mast Cell Diseases (AIM)","volume":"9","author":"Bonadonna","year":"2021","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.iac.2023.04.002_bib59","article-title":"Outcomes of COVID-19 vaccination in 323 patients with clonal and non-clonal mast cell activation disorders","author":"Giannetti","year":"2022","journal-title":"Allergy"},{"issue":"1","key":"10.1016\/j.iac.2023.04.002_bib60","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1159\/000321954","article-title":"Clinical impact of pregnancy in mastocytosis: A study of the Spanish network on mastocytosis (REMA) in 45 cases","volume":"156","author":"Matito","year":"2011","journal-title":"Int Arch Allergy Immunol"}],"container-title":["Immunology and Allergy Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889856123000309?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889856123000309?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T10:53:04Z","timestamp":1760179984000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0889856123000309"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11]]},"references-count":60,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2023,11]]}},"alternative-id":["S0889856123000309"],"URL":"https:\/\/doi.org\/10.1016\/j.iac.2023.04.002","relation":{},"ISSN":["0889-8561"],"issn-type":[{"value":"0889-8561","type":"print"}],"subject":[],"published":{"date-parts":[[2023,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Drug and Venom Allergy in Mastocytosis","name":"articletitle","label":"Article Title"},{"value":"Immunology and Allergy Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.iac.2023.04.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}